Company Response
KRONOX Lab Sciences Limited states that it has always disclosed all material information to the stock exchange in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 within stipulated timeframes.
The management explicitly states that it is "in no way connected with the increase in volume of the shares across stock exchanges."
Compliance Commitment
The company reiterates its commitment to compliance with all applicable regulations and requests BSE to take their clarification on record.
Financial Impact
No financial impact or quantitative details regarding the volume surge are disclosed in the filing. The company does not provide any numerical data about the magnitude of volume increase or trading statistics.